Amin Motamed Ektesabi

Dr. Amin Motamed Ektesabi

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2025 in Cells
Verified
Journal Article
Open access
PDF file
SGSahil Gupta
Sahil Gupta
MLMonica Aida Lopez
Monica Aida Lopez
AEAmin Motamed Ektesabi
Amin Motamed Ektesabi
JTJim Tsoporis
Jim Tsoporis
Chirag M. VaswaniChirag M. Vaswani
Chirag M. Vaswani
JMJohn C Marshall
John C Marshall
The canonical function of caspase-8 is to control timely cellular apoptosis to maintain tissue homeostasis and clear dysfunctional cells; however, emerging findings reveal novel, non-canonical roles of caspase in addition to regulating cellular apoptosis, including inflammatory response regulation, immune function, and cell differentiation. Furthermore, the functional versatility of caspase-8 is reported to be contingent on the presence and dimerization of various isoforms, which are produced through alternative splicing, altering its function and protein–protein interactions. Equally important are post-translational modifications, including phosphorylation and ubiquitination, which can act as a nexus to control caspase-8 activity and cellular localization. Here, we review the alternative splicing and post-translational modifications made to caspase-8 and discuss their influence on its canonical and non-canonical roles.

12 August 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
GKGeorgios Kallinikas
Georgios Kallinikas
AEAmin Motamed Ektesabi
Amin Motamed Ektesabi
Chirag M. VaswaniChirag M. Vaswani
Chirag M. Vaswani
GCGeorgios Charonis
Georgios Charonis
EKEirini Kallinika
Eirini Kallinika
JTJim Tsoporis
Jim Tsoporis
(1) Background: The gold standard, prostate-specific antigen (PSA) screening lacks the sensitivity and specificity required for confident, early prostate-cancer detection. MicroRNAs (miRNAs) are small, highly stable, non-coding RNAs whose expression changes reproducibly in malignancy and therefore offer promise as minimally invasive biomarkers. Although prostate cancer biopsies are the gold standard for prostate cancer diagnosis, limitations in the field continue to persist. Since circulating fluids can also be a source of miRNA biomarkers, we investigated the overlap between miRNAs enriched in prostate cancer tissue and those isolated from the plasma of patients with prostate cancer. (2) Methods: We synthesized the published literature (PubMed, Google Scholar, ResearchGate, 2005–April 2025) and re-analyzed three Gene Expression Omnibus (GEO) datasets (GSE54516, GSE21032—tissue; GSE206793—plasma) to identify miRNAs consistently dysregulated in prostate cancer tissue and circulation. (3) Results: Of the 318 screened full-text articles, 24 met the inclusion criteria. From the GEO reanalysis (false-discovery-rate < 0.05, |log2FC| ≥ 1), 219 and 326 miRNAs were differentially expressed in tissue, whereas 12 were altered in plasma. Two miRNAs—miR-449b and miR-455-3p—were common in both compartments, highlighting their translational potential as liquid biopsy surrogates of tumor biology. (4) Conclusions: We summarize functional evidence for leading tumor-suppressive (e.g., miR-205, miR-23b, miR-455-3p) and oncogenic (e.g., miR-21, miR-182, miR-449b) candidates, discuss their intersection with the androgen-receptor, TGF-β, WNT/β-catenin, and PI3K-AKT signaling, and outline outstanding requirements for the clinical qualification of miRNA panels in prostate cancer.

24 February 2023 in Antioxidants
Verified
Journal Article
Open access
PDF file
JTJim Tsoporis
Jim Tsoporis
HAHajera Amatullah
Hajera Amatullah
SGSahil Gupta
Sahil Gupta
SIShehla Izhar
Shehla Izhar
AEAmin Motamed Ektesabi
Amin Motamed Ektesabi
claudia C dos Santosclaudia C dos Santos
claudia C dos Santos
Oxidative stress is considered one of the early underlying contributors of sepsis-induced myocardial depression. DJ-1, also known as PARK7, has a well-established role as an antioxidant. We have previously shown, in a clinically relevant model of polymicrobial sepsis, DJ-1 deficiency improved survival and bacterial clearance by decreasing ROS production. In the present study, we investigated the role of DJ-1 in sepsis-induced myocardial depression. Here we compared wildtype (WT) with DJ-1 deficient mice at 24 and 48 h after cecal ligation and puncture (CLP). In WT mice, DJ-1 was increased in the myocardium post-CLP. DJ-1 deficient mice, despite enhanced inflammatory and oxidative responses, had an attenuated hypertrophic phenotype, less apoptosis, improved mitochondrial function, and autophagy, that was associated with preservation of myocardial function and improved survival compared to WT mice post-CLP. Collectively, these results identify DJ-1 as a regulator of myocardial function and as such, makes it an attractive therapeutic target in the treatment of early sepsis-induced myocardial depression.

Verified
Journal Article
Open access
PDF file
Chirag M. VaswaniChirag M. Vaswani
Chirag M. Vaswani
JSJulia Simone
Julia Simone
JPJacqueline L. Pavelick
Jacqueline L. Pavelick
XWXiao Wu
Xiao Wu
GTGreaton W. Tan
Greaton W. Tan
claudia C dos Santosclaudia C dos Santos
claudia C dos Santos
Acute Respiratory Distress Syndrome (ARDS) is characterized by lung inflammation and increased membrane permeability, which represents the leading cause of mortality in ICUs. Mechanical ventilation strategies are at the forefront of supportive approaches for ARDS. Recently, an increasing understanding of RNA biology, function, and regulation, as well as the success of RNA vaccines, has spurred enthusiasm for the emergence of novel RNA-based therapeutics. The most common types of RNA seen in development are silencing (si)RNAs, antisense oligonucleotide therapy (ASO), and messenger (m)RNAs that collectively account for 80% of the RNA therapeutics pipeline. These three RNA platforms are the most mature, with approved products and demonstrated commercial success. Most recently, miRNAs have emerged as pivotal regulators of gene expression. Their dysregulation in various clinical conditions offers insights into ARDS pathogenesis and offers the innovative possibility of using microRNAs as targeted therapy. This review synthesizes the current state of the literature to contextualize the therapeutic potential of miRNA modulation. It considers the potential for miR-based therapeutics as a nuanced approach that incorporates the complexity of ARDS pathophysiology and the multifaceted nature of miRNA interactions.

1 May 2020
Verified
Conference Paper
Closed access
Chirag M. VaswaniChirag M. Vaswani
Chirag M. Vaswani
AVA.K. Varkouhi
A.K. Varkouhi
ATA.P. Teixeira
A.P. Teixeira
AEAmin Motamed Ektesabi
Amin Motamed Ektesabi
MKM. Kim
M. Kim
claudia C dos Santosclaudia C dos Santos
claudia C dos Santos

Verified
Journal Article
Open access
PDF file
GKGeorgios Kallinikas
Georgios Kallinikas
GCGeorgios Charonis
Georgios Charonis
EKEirini Kallinika
Eirini Kallinika
DKDiomidis Kozyrakis
Diomidis Kozyrakis
EREvangelos Rodinos
Evangelos Rodinos
JTJim Tsoporis
Jim Tsoporis
Diabetic bladder dysfunction (DBD) comprises a wide spectrum of lower urinary tract symptoms that impact diabetic patients’ lives, including urinary frequency, urgency, incontinence, and incomplete bladder emptying. To relieve symptoms, anticholinergics have been widely prescribed and are considered an effective treatment. There is increasing evidence that diabetic patients may benefit from the use of phosphodiesterase 5 (PDE5) inhibitors. This narrative review aims to provide a brief overview of the pathophysiology of DBD along with a focus on cholinergic and phosphodiesterase inhibitors as therapies that benefit DBD. An examination of the literature suggests compelling avenues of research and underscores critical gaps in understanding the mechanisms underlying DBD. New tools and models, especially rodent models, are required to further elucidate the mechanisms of action of current therapies in the treatment of DBS.